Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005

Journal of Medical Virology

Volumn 78, Issue 8, 2006, Pages 997-1002

  Babič, Dunja Z ^a   Poljak, Mario ^a   Seme, Katja ^a   Tomažič, Janez ^b   Vidmar, Ludvik ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Circulating recombinant forms; HIV 1; Slovenia; Subtypes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EASTERN EUROPE; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR; SLOVENIA; STRUCTURAL GENE; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN EUROPE;

ADULT; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENE PRODUCTS, POL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; SLOVENIA; TIME FACTORS; VARIATION (GENETICS);

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745726978     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20654     Document Type: Article

References (25)

1. Boni J, Pyra H, Gebhardt M, Perrin L, Burgisser P, Matter L, Fierz W, Erb P, Piffaretti JC, Minder E, Grob P, Burckhardt JJ, Zwahlen M, Schupbach J. 1999. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 22:174-179.
2. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, Simon F. 2000. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS 14:289-296.
3. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, van Rensburg EJ, Wensing AM, van de Vijver DA, Boucher CA, Camacho R, Vandamme AM. 2005. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21:3797-3800.
4. Deroo S, Robert I, Fontaine E, Lambert C, Plesseria JM, Arendt V, Staub T, Hemmer R, Schneider F, Schmit JC. 2002. HIV-1 subtypes in Luxembourg, 1983-2000. AIDS 16:2461-2467.
5. Esteves A, Parreira R, Venenno T, Franco M, Piedade J, Germano De Sousa J, Canas-Ferreira WF. 2002. Molecular epidemiology of HIV type 1 infection in Portugal: High prevalence of non-B subtypes. AIDS Res Hum Retroviruses 18:313-325.
6. Hall T. 1999. Bioedit: A user-friendly biological sequence alignment editor and analysis program for Windows 96/98/NT. Nucleic Acid Symp Ser 41:95-98.
7. Klavs I, Poljak M. 2003. Unlinked anonymous monitoring of human immunodeficiency virus prevalence in high- and low-risk groups in Slovenia, 1993-2002. Croat Med J 44:545-549.
8. Kumar S, Tamura K, Nei M. 2004. MEGA 3: Integrated software for Molecular evolutionary genetics analysis and sequence alignment. Briefings in Bioinformatics 5:150-163.
9. Lospitao E, Alvarez A, Soriano V, Holguin A. 2005. HIV-1 subtypes in Spain: A retrospective analysis from 1995 to 2003. HIV Med 6:313-320.
10. Luft S, Seme K, Poljak M. 2004. Laboratory diagnosis of human immunodeficiency virus infection. Acta Dermatovenerol Alp Panonica Adriat 13:43-49.
11. Mezei M, Balog K, Takacs M, Toth G, Gyuris A, Segesdi J, Bakos A, Vodros D, Banhegyi D, Berencsi G, Minarovits J. 2000. Genetic subtypes of HIV type 1 in Hungary. AIDS Res Hum Retroviruses 16:513-516.
12. Mezei M, Balog K, Babič DZ, Toth G, Cech G, Vajna B, Tauber T, Seme K, Tomažič J, Vidmar L, Poljak M, Minarovits J. 2006. Genetic variability of gag and env regions of HIV-1 strains circulating in Slovenia. AIDS Res Hum Retroviruses 22:109-113.
13. Monno L, Brindicci G, Lo Caputo S, Punzi G, Scarabaggio T, Riva C, Di Bari C, Pierotti P, Saracino A, Lagioia A, Mazzotta F, Balotta C, Angarano G. 2005. HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. J Med Virol 75:483-490.
14. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J; WHO-UNAIDS Network for HIV Isolation and Characterization. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 29:184-190.
15. Peeters M. 2001. The genetic variability of HIV-1 and its implications. Transfus Clin Biol 8:222-225.
16. Perrin L, Kaiser L, Yerly S. 2003. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 3:22-27.
17. Poljak M, Tomažič J, Seme K, Matičič M, Vidmar L. 1998. Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals. Acta Virol 42:23-26.
18. Poljak M, Seme K, Marin IJ, Tomažič J, Vidmar L, Matičič M, Kasper P. 2000. Seroprevalence of HIV-1 subtypes A-E among HIV-1 infected individuals from Slovenia. Pflugers Arch 439:R45-R46.
19. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
20. Sides TL, Akinsete O, Henry K, Wotton JT, Carr PW, Bartkus J. 2005. HIV-1 subtype diversity in Minnesota. J Infect Dis 192:37-45.
21. Snoeck J, Van Laethem K, Hermans P, Van Wijngaerden E, Derdelinckx I, Schrooten Y, van de Vijver DA, De Wit S, Clumeck N, Vandamme AM. 2004. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J Acquir Immune Defic Syndr 35:279-285.
22. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882.
23. Thomson MM, Najera R. 2001. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis 32:1732-1737.
24. Weidle PJ, Ganea CE, Irwin KL, Pieniazek D, McGowan JP, Olivo N, Ramos A, Schable C, Lal RB, Holmberg SD, Ernst JA. 2000. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis 181:470-475.
25. Wensing AM, van de Vijver DA, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme. 2005. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 192:958-966.